Morgan Stanley’s Altimeter Growth Corp 2 AGCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,738
Closed -$17K 8048
2022
Q3
$17K Buy
1,738
+38
+2% +$376 ﹤0.01% 6877
2022
Q2
$17K Sell
1,700
-6,232
-79% -$61.2K ﹤0.01% 7058
2022
Q1
$77K Sell
7,932
-51,667
-87% -$506K ﹤0.01% 6478
2021
Q4
$588K Sell
59,599
-58,267
-49% -$583K ﹤0.01% 5449
2021
Q3
$1.17M Sell
117,866
-452
-0.4% -$4.5K ﹤0.01% 4953
2021
Q2
$1.21M Buy
118,318
+57,168
+93% +$601K ﹤0.01% 4967
2021
Q1
$634K Buy
+61,150
New +$730K ﹤0.01% 5026

Morgan Stanley's AGCB Position: Q4 2022 in Review

Morgan Stanley sold out of Altimeter Growth Corp 2 (AGCB) in Q4 2022, closing a stake of 1,738 shares — an estimated $17K sold.

Morgan Stanley first reported a position in AGCB in Q1 2021 and held it in 7 quarters. The position peaked at $1.21M in Q2 2021. 0 funds tracked by Wall St. Rank hold AGCB as of Q4 2022.

  • Morgan Stanley reported no remaining Altimeter Growth Corp 2 position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 1,738 Altimeter Growth Corp 2 shares in Q4 2022, an estimated $17K.
  • Morgan Stanley first reported a position in Altimeter Growth Corp 2 in Q1 2021 and held it in 7 quarters.
  • Morgan Stanley's Altimeter Growth Corp 2 position peaked at $1.21M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Altimeter Growth Corp 2 as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.